Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Circulating cell-free nucleic acids: main characteristics and clinical application
Liquid biopsy recently became a very promising diagnostic method that has several
advantages over conventional invasive methods. Liquid biopsy may serve as a source of …
advantages over conventional invasive methods. Liquid biopsy may serve as a source of …
Circulating cell-free nucleic acids: characteristics and applications
Liquid biopsy is becoming a very popular sample obtaining procedure, replacing the
invasive sampling methods for the diagnostic protocols. The advantages of this method …
invasive sampling methods for the diagnostic protocols. The advantages of this method …
Free DNA in the serum of cancer patients and the effect of therapy
SA Leon, B Shapiro, DM Sklaroff, MJ Yaros - Cancer research, 1977 - AACR
A radioimmunoassay for ng quantities of DNA was developed.[125I] Iododeoxyuridine-
labeled DNA was used as the antigen, and the serum of a lupus erythematosus patient …
labeled DNA was used as the antigen, and the serum of a lupus erythematosus patient …
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells
S Jahr, H Hentze, S Englisch, D Hardt, FO Fackelmayer… - Cancer research, 2001 - AACR
Increased levels of DNA fragments have frequently been found in the blood plasma of
cancer patients. Published data suggest that only a fraction of the DNA in blood plasma is …
cancer patients. Published data suggest that only a fraction of the DNA in blood plasma is …
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients
P Anker, H Mulcahy, X Qi Chen, M Stroun - Cancer and Metastasis …, 1999 - Springer
Small amounts of free DNA circulate in both healthy and diseased human plasma/serum,
and increased concentrations of DNA are present in the plasma of cancer patients …
and increased concentrations of DNA are present in the plasma of cancer patients …
Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
B Shapiro, M Chakrabarty, EM Cohn, SA Leon - Cancer, 1983 - Wiley Online Library
Previous studies showed that patients with neoplasms of various types and origins have
abnormally high concentration of DNA in their serum. The current work compares circulating …
abnormally high concentration of DNA in their serum. The current work compares circulating …
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance
The presence of small amounts of tumor DNA in cell free DNA (CFDNA) circulating in the
plasma or serum of cancer patients was first demonstrated 30 years ago. Since then, overall …
plasma or serum of cancer patients was first demonstrated 30 years ago. Since then, overall …
[HTML][HTML] Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer
TJ Oh, N Kim, Y Moon, MS Kim, BD Hoehn… - The Journal of Molecular …, 2013 - Elsevier
Aberrant DNA methylation has shown promise as a biomarker for the early detection of
cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer …
cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer …
Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool
Background: Evaluation of tumor-specific circulating DNA in plasma/serum is a promising
noninvasive diagnostic and prognostic tool requiring only a blood sample, which …
noninvasive diagnostic and prognostic tool requiring only a blood sample, which …
Characterization of circulating DNA in healthy human plasma
N Suzuki, A Kamataki, J Yamaki, Y Homma - Clinica chimica acta, 2008 - Elsevier
BACKGROUND: The importance of circulating DNA has been recognized since the
detection of mutated oncogene products in cancer patients; however, there is little …
detection of mutated oncogene products in cancer patients; however, there is little …